Back to Search Start Over

Performance of non-invasive tests for liver fibrosis resolution after bariatric surgery.

Authors :
Raverdy, Violeta
Tavaglione, Federica
Chatelain, Estelle
Caiazzo, Robert
Saponaro, Chiara
Lassailly, Guillaume
Verkindt, Helene
Baud, Gregory
Marciniak, Camille
Chetboun, Mikael
Oukhouya-Daoud, Naima
Gnemmi, Viviane
Leteurtre, Emmanuelle
Duhamel, Alain
Philippe, Mathurin
Marot, Guillemette
Romeo, Stefano
Pattou, François
Source :
Metabolism: Clinical & Experimental; Apr2024, Vol. 153, pN.PAG-N.PAG, 1p
Publication Year :
2024

Abstract

The value of non-invasive tests for monitoring the resolution of significant liver fibrosis after treatment is poorly investigated. We compared the performances of six non-invasive tests to predict the resolution of significant fibrosis after bariatric surgery. Participants were individuals with obesity submitted to needle liver biopsy at the time of bariatric surgery, and 12 and/or 60 months after surgery. We calculated the fibrosis-4 index (FIB-4), NAFLD fibrosis score (NFS), AST to platelet ratio index (APRI), Hepatic fibrosis score (HFS), Fibrotic NASH index (FNI), and Liver risk score (LRS) at each time point, and compared their performances for predicting significant fibrosis (F ≥ 2) and its resolution following surgery. At baseline, 2436 patients had liver biopsy, including 261 (10.7 %) with significant fibrosis. Overall, 672 patients had pre- and post-operative biopsies (564 at M12 and 328 at M60). The fibrosis stage decreased at M12 and M60 (p < 0.001 vs M0). Resolution of significant fibrosis occurred in 58/121 (47.9 %) at M12 and 32/50 (64 %) at M60. The mean value of all tests decreased after surgery, except for FIB-4. Performances for predicting fibrosis resolution was higher at M60 than at M12 for all tests, and maximal at M60 for FNI and LRS: area under the curve 0.843 (95%CI 0.71–0.95) and 0.92 (95%CI 0.84–1.00); positive likelihood ratio 3.75 (95 % CI 1.33–10.59) and 4.58 (95 % CI 1.65–12.70), respectively. Results showed the value and limits of non-invasive tests for monitoring the evolution of liver fibrosis after an intervention. Following bariatric surgery, the best performances to predict the resolution of significant fibrosis were observed at M60 with tests combining liver and metabolic traits, namely FNI and LRS. [Display omitted] • Bariatric surgery (BS) leads to the resolution of significant fibrosis in 64% of cases at 5 years • The performance of NITs for monitoring the resolution of fibrosis was limited at 1 year and improved at 5 years after BS • NITs including metabolic parameters showed better performance in predicting the resolution of fibrosis after BS [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00260495
Volume :
153
Database :
Supplemental Index
Journal :
Metabolism: Clinical & Experimental
Publication Type :
Academic Journal
Accession number :
175774345
Full Text :
https://doi.org/10.1016/j.metabol.2024.155790